Dr. Jon Abramson, a pharmaceutical safety and ethics expert at the Harvard Medical School. "Unless health care reform can address misrepresentations, withholding science and control claims made to consumers, Americans will continue to pay too much for health care that is not as effective and is expensive." (ABCNews.com)
"It's hard to do what's right when everyone else around you is following management sales directive," Pfizer whistleblower John Kopchinski told the BBC's World Today.
"In the Army I was expected to protect people at all costs," Kopchinski said in a statement. "At Pfizer I was expected to increase profits at all costs, even when sales meant endangering lives." (Reuters)
"There's so much money in selling pills, that there's a tremendous temptation to cheat," said Bill Vaughan, an analyst at Consumers Union, the nonprofit publisher of Consumer Reports. "There's a kind of mentality in this sector that (settlements) are the cost of doing business and we can cheat,'' he said. "This penalty is so huge I think consumers can have some hope that maybe these guys will tighten up and run a better ship." (Star-Ledger)
"What you see here is a company which essentially had a culture of corruption," said Patrick Burns, a spokesman for Taxpayers Against Fraud, a U.S. nonprofit organization that helps connect whistleblowers with attorneys on False Claims Act cases. (Reuters)